Gleason Score 6 Prostate Carcinoma and Presence of Pathological Stage T3 Disease

被引：0
|
作者：
Razmaria, A. A. [1 ]
Negron, E. [1 ]
Zagaja, G. P. [1 ]
Shalhav, A. L. [1 ]
Eggener, S. E. [1 ]
Paner, G. P. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1047
引用
收藏
页码：254A / 254A
页数：1
相关论文
共 50 条
  • [41] Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update
    Partin, AW
    Kattan, MW
    Subong, EN
    Walsh, PC
    Wojno, KJ
    Oesterling, JE
    Scardino, PT
    Pearson, JD
    Graefen, M
    AKTUELLE UROLOGIE, 2004, 35 (05) : 377 - 378
  • [42] Combination of prostate-specific antigen, clinical stage, and gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update
    Partin, AW
    Kattan, MW
    Subong, ENP
    Walsh, PC
    Wojno, KJ
    Oesterling, JE
    Scardino, PT
    Pearson, JD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1445 - 1451
  • [43] IS PATHOLOGICAL UPSTAGING TO T3 RENAL CELL CARCINOMA ASSOCIATED WITH A SIMILAR PROGNOSIS TO NON-UPSTAGED PATHOLOGIC T3 DISEASE? A MULTICENTER ANALYSIS
    Nasseri, Ryan
    Hakimi, Kevin
    Saidian, Ava
    Autorino, Riccardo
    Lane, Brian
    Fujii, Yasuha
    Marchioni, Michele
    Tanaka, Hajime
    Patil, Dattatraya
    Porpiglia, Francesco
    Noyes, Sabrina
    Sundaram, Chandru
    Porter, James
    Minervini, Andrea
    Capitianio, Umberto
    Montorsi, Francesco
    Master, Viraj
    Derweesh, Ithaar
    JOURNAL OF UROLOGY, 2022, 207 (05): : E396 - E397
  • [44] IMPROVED CONCORDANCE OF BIOPSY AND PATHOLOGICAL GLEASON SCORE USING QUANTITATIVE GLEASON GRADING OF PROSTATE BIOPSY SPECIMENS
    Reese, Adam
    Cooperberg, Matthew
    Cowan, Janet
    Brajtbord, Jonathan
    Harris, Catherine
    Carroll, Peter
    JOURNAL OF UROLOGY, 2011, 185 (04): : E79 - E79
  • [45] Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?
    Pelzer, Alexandre E.
    Colleselli, Daniela
    Bektic, Jasmin
    Steiner, Eberhard
    Ramoner, Reinhold
    Mitterberger, Michael
    Schwentner, Christian
    Schaefer, Georg
    Ongarello, Stefano
    Bartsch, Georg
    Horninger, Wolfgang
    BJU INTERNATIONAL, 2008, 101 (07) : 822 - 825
  • [46] PTEN and ERG Status of Intraductal Carcinoma of the Prostate Occurring with Invasive Gleason Score 6 Carcinoma at Needle Biopsy
    Tregnago, Aline C.
    Hicks, Jessica L.
    DeMarzo, Angelo
    Epstein, Jonathan
    Lotan, Tamara L.
    MODERN PATHOLOGY, 2018, 31 : 392 - 392
  • [47] Radical prostatectomy for clinical stage T3 disease
    Freedland, Stephen J.
    Partin, Alan W.
    Humphreys, Elizabeth B.
    Mangold, Leslie A.
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 243 - 243
  • [48] PTEN and ERG Status of Intraductal Carcinoma of the Prostate Occurring with Invasive Gleason Score 6 Carcinoma at Needle Biopsy
    Tregnago, Aline C.
    Hicks, Jessica L.
    DeMarzo, Angelo
    Epstein, Jonathan
    Lotan, Tamara L.
    LABORATORY INVESTIGATION, 2018, 98 : 392 - 392
  • [49] Can We Predict Real T3 Stage Prostate Cancer in Patients with Clinical T3 (cT3) Disease before Radical Prostatectomy?
    Lee, Hye Won
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    YONSEI MEDICAL JOURNAL, 2010, 51 (05) : 700 - 707
  • [50] The impact of prostate-specific antigen, its density and the Gleason score in the prediction of extracapsular disease in prostate carcinoma
    Akdas, A
    Tarcan, T
    Turkeri, L
    Biren, T
    Kullu, S
    Ilker, Y
    EUROPEAN UROLOGY, 1997, 31 (03) : 311 - 316
12345